Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials

Vasc Med. 2019 Apr;24(2):156-158. doi: 10.1177/1358863X18818319. Epub 2019 Feb 12.

Authors

Gerald Chi¹, Sadaf Sharfaei¹, Mehrian Jafarizade¹, Farima Kahe¹, Yuyin Liu²

Affiliations

¹ 1 Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
² 2 Baim Institute for Clinical Research, Boston, MA, USA.

PMID: 30755140
DOI: 10.1177/1358863X18818319

No abstract available

Keywords: deep vein thrombosis (DVT); direct oral anticoagulant (DOAC); pulmonary embolism (PE); venous thromboembolism (VTE).

Publication types

Meta-Analysis

MeSH terms

Clinical Decision-Making
Drug Administration Schedule
Fibrinolytic Agents* / administration & dosage
Fibrinolytic Agents* / adverse effects
Hemorrhage / chemically induced
Hospitalization*
Humans
Inpatients*
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Venous Thromboembolism* / diagnosis
Venous Thromboembolism* / etiology
Venous Thromboembolism* / mortality
Venous Thromboembolism* / prevention & control

Substances

Fibrinolytic Agents